Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3351
GeneDx Holdings
WGS
$1.64B
| $558K | ﹤0.01% |
7,711
-89,523
| -92% | -$6.94M |
2024 Q2
9 quarters
|
|
3352
Ranger Energy Services
RNGR
$291M
| $557K | ﹤0.01% |
36,681
+1,588
| +5% | +$25.8K |
2022 Q3
16 quarters
|
|
3353
CryoPort
CYRX
$1.04B
| $557K | ﹤0.01% |
31,983
-6,914
| -18% | -$110K |
2017 Q4
35 quarters
|
|
3354
STAAR Surgical
STAA
$1.34B
| $556K | ﹤0.01% |
24,581
+10,069
| +69% | +$242K |
2016 Q3
40 quarters
|
|
3355
Amphastar Pharmaceuticals
AMPH
$1.22B
| $554K | ﹤0.01% |
21,483
-3,734
| -15% | -$80.7K |
2014 Q4
47 quarters
|
|
3356
UMH Properties
UMH
$1.27B
| $554K | ﹤0.01% |
35,994
-18,606
| -34% | -$293K |
2019 Q1
30 quarters
|
|
3357
Franklin Financial Services
FRAF
$315M
| $554K | ﹤0.01% |
8,964
+1,074
| +14% | +$67.5K |
2024 Q3
8 quarters
|
|
3358
Uniti Group
UNIT
$988M
| $554K | ﹤0.01% |
66,064
+34,489
| +109% | +$347K |
2015 Q2
45 quarters
|
|
3359
Western New England Bancorp
WNEB
$271M
| $553K | ﹤0.01% |
40,379
+4,517
| +13% | +$62.9K |
2022 Q3
16 quarters
|
|
3360
iShares US Medical Devices ETF
IHI
$4.07B
| $551K | ﹤0.01% |
10,780
+5,267
| +96% | +$278K |
2020 Q2
25 quarters
|
|
3361
CALL
CarMax
KMX
$7.65B
| $551K | ﹤0.01% |
+10,000
| New | +$582K |
2026 Q3
0 quarters
|
|
3362
Virtus Investment Partners
VRTS
$852M
| $550K | ﹤0.01% |
4,156
+1,078
| +35% | +$168K |
2016 Q1
42 quarters
|
|
3363
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$3.6B
| $549K | ﹤0.01% |
5,300
| – | – |
2026 Q2
1 quarter
|
|
3364
BayCom
BCML
$341M
| $547K | ﹤0.01% |
18,044
+2,680
| +17% | +$83.7K |
2018 Q2
33 quarters
|
|
3365
Senseonics Holdings Inc
SENS
$551M
| $547K | ﹤0.01% |
53,768
+45,133
| +523% | +$339K |
2025 Q4
3 quarters
|
|
3366
J&J Snack Foods
JJSF
$1.66B
| $547K | ﹤0.01% |
7,150
+3,759
| +111% | +$308K |
2016 Q1
42 quarters
|
|
3367
Helen of Troy
HELE
$888M
| $546K | ﹤0.01% |
19,931
+15,874
| +391% | +$449K |
2013 Q4
51 quarters
|
|
3368
PUT
MetLife
MET
$64.7B
| $546K | ﹤0.01% |
+5,800
| New | +$553K |
2026 Q3
0 quarters
|
|
3369
Worthington Steel
WS
$2.02B
| $545K | ﹤0.01% |
15,476
+8,163
| +112% | +$287K |
2023 Q4
11 quarters
|
|
3370
Arlo Technologies
ARLO
$1.32B
| $545K | ﹤0.01% |
43,942
+25,028
| +132% | +$339K |
2018 Q3
32 quarters
|
|
3371
Kelly Services Class A
KELYA
$481M
| $544K | ﹤0.01% |
33,562
+8,348
| +33% | +$131K |
2016 Q1
42 quarters
|
|
3372
Tyra Biosciences
TYRA
$1.44B
| $543K | ﹤0.01% |
24,841
+4,566
| +23% | +$126K |
2022 Q1
18 quarters
|
|
3373
Fidelity D&D Bancorp
FDBC
$393M
| $542K | ﹤0.01% |
9,977
+342
| +4% | +$18.3K |
2018 Q2
33 quarters
|
|
3374
HIVE Digital Technologies
HIVE
$480M
| $542K | ﹤0.01% |
183,643
+161,527
| +730% | +$487K |
2026 Q1
2 quarters
|
|
3375
Trustco Bank Corp NY
TRST
$957M
| $542K | ﹤0.01% |
9,978
+441
| +5% | +$24.9K |
2022 Q1
18 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.